Dr. Carl Ola Landgren, Author at Curetalks

Dr. Carl Ola Landgren | CureTalks

Dr. Carl Ola Landgren is Professor of Medicine, chief of Myeloma Program and leader of Experimental Therapeutics Program at the University of Miami. He is a board-certified hematologist-oncologist affiliated with Memorial Sloan Kettering Cancer Center. His research focuses on the mechanisms underlying progression from precursor disease to frank malignancy; prognostic factors associated with progression; role of MRD (minimal residual disease) negativity and biological mechanisms associated with MRD status drug development; identification of novel targets and intervention of residual/refractory disease. His area of expertise include Myeloma, Monoclonal Gammopathy, MGUS, and Smoldering Myeloma. Dr. Landgren received his medical degree from Karolinska Institute Faculty of Medicine and has been practicing for more than 20 years.

Related Talks